Publications

Rx-360 Guidance and Best Practices for Raw Material Supply Chain Security for Cell and Gene Therapies

May 13, 2021

Cell and gene therapies (CGT) are novel therapeutic modalities with greater than one thousand clinical trials ongoing globally.   The unmet need for treatment options and the promise of these therapies has prompted regulatory agencies world-wide […]